<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Furthermore, an experimental randomized controlled trial of 99 diabetes patients received the placebo and two treatment groups received oral black seed oil. Administration of 1.5 and 3 mL/day of black seed oil for 20 days showed meaningful reduction of glycated hemoglobin A1c and random blood sugar levels [
 <xref rid="B48" ref-type="bibr" class="xref">48</xref>]. The effect of
 <italic class="italic"> N. sativa</italic> seed on the glycemic control of patients with type-2 diabetes (DM-2) was also used as an adjunctive treatment added to their oral hypoglycemic agents.
 <italic class="italic"> N. sativa</italic> at a dose of two g/day also influenced substantial reductions in fasting plasma glucose and glycated hemoglobin (HbA1c) without major alteration in body weight [
 <xref rid="B49" ref-type="bibr" class="xref">49</xref>]. The oil of
 <italic class="italic"> N. sativa </italic>(NSO) at 2 mL/kg also was showed to reduce fasting plasma glucose and intensification of insulin levels in diabetic rats compared to control. Diabetic rats that received NSO exhibited substantial improvements in lipid profile and expressive increment of pancreatic and hepatic antioxidant enzymes also augmented the histological image and glycogen contents other than improvements of average pancreatic islet extent than the diabetic groups [
 <xref rid="B50" ref-type="bibr" class="xref">50</xref>].
</p>
